Pyridazino quinoline compounds
US6232313A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1998 |
| Grant date | May 15, 2001 |
| Priority date | — |
| Expiry date | Mar 19, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, pharmaceutical compositions and methods of using compounds having the formula below ##STR1## in the treatment and prevention of certain diseases or conditions. Where the ring designated A is chosen from ortho substituted aryl or heteroaryl species, R.sup.1 and R.sup.2 are chosen independently from --(CH.sub.2).sub.n L where L is selected from a variety of substituents including hydrogen, and aryl, heteroaryl or heterocyclic groups and R.sup.4 is chosen from a variety of substituents including halogen and alkyl groups. The compounds are useful in treating and preventing neurological disorders associated with excitatory amino acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.